1. Predicting the probability of survival with mild or moderate neurological dysfunction after in-hospital cardiopulmonary arrest: The GO-FAR 2 score.
- Author
-
George N, Thai TN, Chan PS, and Ebell MH
- Subjects
- Aged, Female, Hospital Mortality, Hospitalization statistics & numerical data, Humans, Male, Neurologic Examination methods, Outcome Assessment, Health Care methods, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Factors, Severity of Illness Index, Survival Analysis, United States, Cardiopulmonary Resuscitation adverse effects, Cardiopulmonary Resuscitation methods, Cardiopulmonary Resuscitation statistics & numerical data, Heart Arrest diagnosis, Heart Arrest mortality, Heart Arrest therapy, Nervous System Diseases diagnosis, Nervous System Diseases etiology
- Abstract
Background: The Good Outcome Following Attempted Resuscitation (GO-FAR) Score uses pre-arrest factors to predict survival after In-Hospital Cardiac Arrest (IHCA) with minimal neurological dysfunction, (cerebral performance category (CPC) ≤1). Moderate neurological dysfunction (CPC ≤2) may be a more acceptable outcome., Objective: To predict survival after IHCA with mild or moderate neurological dysfunction based on pre-arrest factors., Methods: 52,468 patients with IHCA from 2012-2017. Data was divided into training (44%), testing (22%), and validation (34%) sets. Univariate analysis was used to identify variables with >3% difference in survival with CPC ≤2. These variables carried forward to the multivariate logistic regression model. The most parsimonious model that best classified patients as having a very poor (≤5%), below average (≤10%), average (11%-30%), or above average (>30%) likelihood of survival with CPC ≤2 was chosen., Results: Age >85, admission CPC <2, and non-surgical admission were strongly association with poor survival (-12.1%, -14.4%, and -18%, respectively). Nine variables were included in the logistic regression analysis. The final updated model, GO FAR 2, categorized 6.2% of patients with a very poor predicted survival, 24.8% of patients with a below average predicted survival, and 11.3% with above average predicted survival. The observed survival among those with very poor predicted survival was 4.5%., Conclusion: The GO FAR 2 score provides clinicians with a prognostic estimate of the likelihood of a good outcome after IHCA based on pre-arrest patient factors. Future research is required to validate the GO-FAR 2 score., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF